Commercialization in Biophotonics: A conversation with David Cuccia and Amaan Mazhar about Modulim
Biophotonics Discovery: The Podcast
In this episode of our commercialization series, Darren and Gwen sit down with David Cuccia (President & CTO) and Amaan Mazhar (CEO) of Modulim, a biophotonics startup developing commercial applications of Spatial Frequency Domain Imaging (SFDI).
David and Amaan share their journey from graduate school at UC Irvine’s Beckman Laser Institute to building a medtech company. The conversation covers practical lessons about FDA regulatory pathways, the importance of quality systems, and how they’re addressing diabetic complications and amputations through tissue oxygenation measurements. They also share valuable insights about finding the right early adopter customers, adapting product form factors based on clinical feedback, and understanding that in medtech, you have multiple “customers”—from the FDA to insurance companies to physicians.
Whether you’re a researcher considering commercialization or simply curious about the path from lab to market, this episode offers an honest, detailed look at building a biophotonics startup.
Click here or visit https://bit.ly/biophotonicspod to listen to the “Biophotonics Discovery: The Podcast” episode.
